Pavani Chalasani MD, MPH
Nan Chen, MD
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Seema A. Khan, MD
Treating Metastatic Breast Cancer: Where Are We Now?
Jacob Sands, MD
Maya Leiva, PharmD, BCOP
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Aditya Bardia, MD, MPH
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Amer Zeidan, MBBS
Amy E. DeZern, MD, MHS
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
Elizabeth Smyth, MD
Jaffer Ajani, MD
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GE…
Lyudmila Bazhenova, MD
Benjamin Levy, MD
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
Andrew M. Brunner, MD
A New Light in Higher-Risk MDS: Emerging Treatment Options
Scott Kopetz, MD, PhD
Elena Elez, MD, PhD
Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer
Kevin Kalinsky MD, MS
Conversations Around Chemotherapy: Do All of Your Patients Need It?
A Look at HIV & Its Link to Cancer
Larry Anderson, MD, PhD
Thomas G. Martin, MD
State of the Union: CAR T Cell Therapy
Jacqueline Garcia, MD
David A. Sallman, MD
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Str…
Manish A. Shah, MD FASCO
Hepatocellular Carcinoma: Evaluating the Evolving Treatment Landscape
Daniel Sessler, MD
Anesthesia Technique & Cancer Recurrence: What Do We Need to Know?
Sara A. Hurvitz, MD, FACP
Paolo Tarantino, MD
Gaining Ground on HER2-Low Breast Cancer Priorities: Shared Decision-Making in Practice
Gaining Ground on HER2-Low Breast Cancer Priorities: Shared Decision-Making in …
Kathleen Fenn, MD
Oudai Hassan, MD
Expert Insights on HER2 Scoring Criteria for Breast Cancer
Stay current with the best on medical education
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.